HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

XUANZHUBIO-B

74.600

+5.3007.65%

Volume:328.57K

Turnover:24.05M

Market Cap:38.64B

PE:-60.41

High:74.600

Open:69.000

Low:69.000

Close:69.300

52wk High:96.900

52wk Low:23.820

Shares:518.00M

HK Float Shares:160.70M

Volume Ratio:1.31

T/O Rate:0.20%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.235

ROE:--

ROA:--

PB:40.50

PE(LYR):-60.41

PS:1072.04

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Xuanzhu Biopharmaceutical (02575) Releases Monthly Return for January 2026

Bulletin Express

XuanZhu Bio-B (02575) Surges Over 7% Again as Piroxiclib Tablet Enters National Reimbursement List, Expected to Greatly Enhance Accessibility

Hong Kong Stocks Movement | Xuanzhu Bio-B (02575) Surges Over 6% in Early Trading, Innovative Drug Piroxiclib Set for National Reimbursement on Jan 1, 2026

XuanZhu Bio-B (02575) Appoints Xu Yanjun as General Manager

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02575"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02575","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"XUANZHUBIO-B","latestPrice":74.6,"timestamp":1770618850067,"preClose":69.3,"halted":0,"volume":328566,"delay":0,"changeRate":0.07647907647907644,"floatShares":160701996,"shares":518000000,"eps":-1.234826,"marketStatus":"Trading","change":5.3,"latestTime":"02-09 14:34:59","open":69,"high":74.6,"low":69,"amount":24049970,"amplitude":0.080808,"askPrice":74.6,"askSize":2500,"bidPrice":74.25,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-1.178,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770624600000},"marketStatusCode":2,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":69.3,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":1.312904,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","floatShares":160701996,"roa":"--","roe":"--","lyrEps":-1.234826,"volumeRatio":1.312904,"shares":518000000,"dividePrice":0,"high":74.6,"amplitude":0.080808,"preClose":69.3,"low":69,"week52Low":23.82,"pbRate":"40.50","psRate":"1072.04","week52High":96.9,"institutionHeld":0,"latestPrice":74.6,"committee":-0.111111,"eps":-1.234826,"divideRate":0,"volume":328566,"delay":0,"ttmEps":-1.178,"open":69,"prevYearClose":70.5,"prevWeekClose":69.3,"prevMonthClose":64.35,"prevQuarterClose":70.5,"fiveDayClose":62.8,"twentyDayClose":65.45,"sixtyDayClose":63.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02575\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02575\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02575\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02575\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02575","date":"2026-02-06","current":-61.88455,"percent":0.230769,"low":-70.039607,"twenty":-57.848985,"median":-54.4959,"eighty":-52.506318,"high":-22.444691,"avg":-53.501014,"sd":7.614602,"marketCap":35893781847},"quantilePoints":[{"date":"2025-10-17","current":-28.93414,"twenty":-27.261252,"median":-24.751919,"eighty":-23.367582,"marketCap":17558430081},{"date":"2025-10-24","current":-50.850969,"twenty":-50.816841,"median":-33.923646,"eighty":-26.424807,"marketCap":30869688284},{"date":"2025-10-31","current":-54.182971,"twenty":-53.663557,"median":-50.808309,"eighty":-28.95487,"marketCap":32941479444},{"date":"2025-11-07","current":-55.367666,"twenty":-55.639174,"median":-53.630543,"eighty":-30.992132,"marketCap":33640708960},{"date":"2025-11-14","current":-54.36116,"twenty":-55.639174,"median":-54.1994,"eighty":-41.200731,"marketCap":33122761170},{"date":"2025-11-21","current":-53.748657,"twenty":-55.319259,"median":-54.136108,"eighty":-50.782713,"marketCap":32734300328},{"date":"2025-11-28","current":-53.384655,"twenty":-55.070724,"median":-54.15954,"eighty":-50.923112,"marketCap":32630710770},{"date":"2025-12-05","current":-54.773392,"twenty":-55.070724,"median":-54.21583,"eighty":-51.627953,"marketCap":33537119402},{"date":"2025-12-12","current":-70.039607,"twenty":-55.665823,"median":-54.261136,"eighty":-53.311356,"marketCap":42963769180},{"date":"2025-12-19","current":-60.019152,"twenty":-56.570931,"median":-54.488669,"eighty":-53.433833,"marketCap":36903780037},{"date":"2025-12-24","current":-59.160975,"twenty":-59.157371,"median":-54.549256,"eighty":-53.581365,"marketCap":36489421805},{"date":"2026-01-02","current":-54.537602,"twenty":-59.158272,"median":-54.690337,"eighty":-53.655303,"marketCap":33770195908},{"date":"2026-01-09","current":-52.983682,"twenty":-59.049917,"median":-54.49123,"eighty":-52.274882,"marketCap":32889684665},{"date":"2026-01-16","current":-58.758617,"twenty":-58.846722,"median":-54.572443,"eighty":-53.169291,"marketCap":36593011363},{"date":"2026-01-23","current":-52.071916,"twenty":-58.705513,"median":-54.4959,"eighty":-52.506318,"marketCap":32397634264},{"date":"2026-01-30","current":-53.326607,"twenty":-57.909955,"median":-54.48995,"eighty":-52.506318,"marketCap":33329940286},{"date":"2026-02-06","current":-57.283358,"twenty":-57.848985,"median":-54.4959,"eighty":-52.506318,"marketCap":35893781847}],"updateTime":1770606403477},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02575\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197726114","title":"Xuanzhu Biopharmaceutical (02575) Releases Monthly Return for January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1197726114","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197726114?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:25","pubTimestamp":1770283535,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co., Ltd. (stock code: 02575) published its Monthly Return for Equity Issuer for the period ended 31 January 2026. According to the report, the total issued share capital...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"1124645799","title":"XuanZhu Bio-B (02575) Surges Over 7% Again as Piroxiclib Tablet Enters National Reimbursement List, Expected to Greatly Enhance Accessibility","url":"https://stock-news.laohu8.com/highlight/detail?id=1124645799","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124645799?lang=en_us&edition=fundamental","pubTime":"2026-01-08 15:18","pubTimestamp":1767856717,"startTime":"0","endTime":"0","summary":"XuanZhu Bio-B (02575) surged more than 7% again. As of the time of writing, the stock was up 6.95%, trading at HKD 58.45, with a turnover of HKD 10.7671 million. On the news front, on December 7,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","BK1191"],"gpt_icon":0},{"id":"1195827868","title":"Hong Kong Stocks Movement | Xuanzhu Bio-B (02575) Surges Over 6% in Early Trading, Innovative Drug Piroxiclib Set for National Reimbursement on Jan 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1195827868","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195827868?lang=en_us&edition=fundamental","pubTime":"2026-01-07 09:58","pubTimestamp":1767751102,"startTime":"0","endTime":"0","summary":"Xuanzhu Bio-B (02575) rose more than 6% during the early trading session. As of the time of writing, the stock was up 2.36%, trading at HKD 52.05, with a turnover of HKD 2.9905 million. The catalyst...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02575","06978","BK1191","BK1161","159992"],"gpt_icon":0},{"id":"1130506739","title":"XuanZhu Bio-B (02575) Appoints Xu Yanjun as General Manager","url":"https://stock-news.laohu8.com/highlight/detail?id=1130506739","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130506739?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:53","pubTimestamp":1767606797,"startTime":"0","endTime":"0","summary":"XuanZhu Bio-B (02575) announced that, upon the recommendation of the company's nomination committee, Ms. Xu Yanjun has been appointed as the General Manager of the company, effective January 5, 2026.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02575"],"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02575\",params:#limit:6,delay:false,,,undefined,":[]}}